Aprea Therapeutics, Inc. (APRE): 10-Q filed Nov 4, 2026

Form type

10-Q

Filing date

Nov 4, 2026

Accession number

0001104659-26-122405

Filer

Aprea Therapeutics, Inc. (CIK 1781983)